BETA-LACTAMASE-HEMMER

European patent · EP2231667 · In force

Register entry

Publication number: EP2231667
Application number: EP09701487
Kind: European patent with effect for Switzerland and Liechtenstein
Status: In force
Specification: Granted
Filed: Jan 15, 2009
Published: Sep 29, 2010
Granted: Sep 4, 2013
Protection ends at the latest: Jan 14, 2029
Next annual fee due: Jan 31, 2027
IPC classes: C07D 471/08 (2006.01)
C07D 487/08 (2006.01)
C07D 519/00 (2006.01)
A61K 31/529 (2006.01)
A61K 31/535 (2006.01)
A61P 31/04 (2006.01)
Priority: US 11533 P 18.01.2008
PCT application: PCT/US2009/031047 15.01.2009
PCT publication: WO2009/091856 23.07.2009
Filing language: English
Source: Swissreg

What the Federal Institute of Intellectual Property published about this title, newest first.

Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
Feb 1, 2023
Change
Published in Swissreg on 01.02.2023
Aug 30, 2022
Merged
Owner
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA → MERCK SHARP & DOHME LLC., 126 East Lincoln Avenue, Rahway, New Jersey 07065, USA
Published in Swissreg on 30.08.2022
Oct 29, 2013
Agent entered
Representative
Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich
Published in Swissreg on 29.10.2013
Sep 4, 2013
Granted
Published in Swissreg on 04.09.2013

MERCK SHARP & DOHME LLC.

126 East Lincoln Avenue, Rahway, New Jersey 07065, US

Dreikönigstrasse 31a, 8002 Zürich